← Open Payments lookup

JACQUELINE GILLERN: Open Payments

NPI 1063982759 · WAYMART, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,414 in 72 payments from 11 companies in 2025. Trend: 2023 $575 · 2024 $1,327 · 2025 $1,414

Food & beverage: $1,414
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.16$266
Otsuka America Pharmaceutical, Inc.7$193
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$179
Neurocrine BioSciences, Inc.12$162
E.R. Squibb & Sons, L.L.C.4$154
Vanda Pharmaceuticals Inc.6$144
Janssen Pharmaceuticals, Inc6$136
ABBVIE INC.5$101
Axsome Therapeutics, Inc.2$38
Supernus Pharmaceuticals, Inc.2$28

Products named: UZEDY, REXULTI, CAPLYTA, INGREZZA, COBENFY, FANAPT, INVEGA SUSTENNA, VRAYLAR.

Industry payments across PA — which companies pay providers there.